# KKH Advisors

> KKH Advisors is a New York strategic communications firm founded by former Financial Times Group editor Kimberly Ha. It works with biotech, medtech, digital-health, and life-sciences companies at high-stakes moments - launches, financings, clinical data, regulatory milestones, IPOs, M&A, and crises - combining narrative development, executive counsel, media relations, investor communications, training, and brand work.

- **Founded:** 2018
- **Headquarters:** New York, United States
- **Founders:** Kimberly Ha (Founder & CEO)
- **Products:** Strategic communications, Executive and transaction counsel, Brand and digital network
- **Notable:** Guided more than 100 startups from stealth toward industry visibility during its first six years, according to Nasdaq., Rang the Nasdaq Closing Bell on June 24, 2024, to mark its sixth anniversary., Advised CG Oncology around its January 2024 IPO, described by BioSpectrum Asia as that year's first biotech IPO.

## Products & services

- **Strategic communications** — Key-message development, corporate narratives, executive visibility, speaking opportunities, presentation coaching, and media training.
- **Executive and transaction counsel** — CEO counsel, media relations, investor relations, crisis management, financing communications, IPO positioning, and M&A communications.
- **Brand and digital network** — Corporate rebranding, social and digital media strategy, website development, and brand development delivered directly or through a specialist network.

## Achievements

- Guided more than 100 startups from stealth toward industry visibility during its first six years, according to Nasdaq.
- Rang the Nasdaq Closing Bell on June 24, 2024, to mark its sixth anniversary.
- Advised CG Oncology around its January 2024 IPO, described by BioSpectrum Asia as that year's first biotech IPO.
- Built a visible portfolio across biotech, medtech, digital biomarkers, gene therapy, cell therapy, and healthcare investing.
- Founder Kimberly Ha has moderated industry discussions on IPO readiness, digital therapeutics, AI in healthcare, and biotech media practice.

## Latest updates

- **2026-05** — KKH appeared as the media contact for Epicrispr Biotechnologies' AAV development and manufacturing partnership with Forge Biologics.
- **2026-03** — Kimberly Ha led an ElevAAte Biotech media workshop with reporters from BioPharma Dive and Endpoints News.
- **2025-06** — Ha moderated a BIO International panel on biotech IPO preparation with speakers from Wilson Sonsini, Sofinnova, Nasdaq, Morgan Stanley, and Ally Bridge Group.
- **2024-06** — KKH Advisors celebrated its sixth anniversary by ringing the Nasdaq Closing Bell in Times Square.
- **2024-01** — Client CG Oncology completed its initial public offering; KKH was listed as media contact.

## Links

- Website: https://www.kkhadvisors.com
- LinkedIn: https://www.linkedin.com/company/kkh-advisors
- Twitter/X: https://twitter.com/pharmaprodigy

---

Profile page: https://yespress.io/kkh-advisors
Published by YesPress — https://yespress.io
Last updated: 2026-09-21